***********************************
Brakke Consulting’s
Animal Health News & Notes for October 28, 2022
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
2022 Flea Control & Heartworm Markets report – pre-order now
Earnings News
Merck
Hill’s Pet Nutrition
Other News
A&M Capital Partners
Algenex
Antech
Bausch + Lomb
Bravo! Pet Foods
BrightPet Nutrition Group
Cleon Capital
Columbus Venture Partners
Gold Line Feeds
Insud Pharma
Mars PetCare
MWI
PBD Biotech
PetDx
PIC
Ralco
United Petfood
VolitionRx
Whistle Health
Zoetis
***************************************
K-STATE OLATHE
Animal Health Workshops and Seminars
Upcoming Events
Advanced Animal Pharmaceutical | Nov. 9-10
This workshop provides a detailed, practical and experienced based review of veterinary drug approval processes. It focuses on four major technical sections comprised of five topics of a U.S. Food and Drug Administration and Center for Veterinary Medicine product submission.
Roadmap to Market: Supply Chain in Animal Health | Dec. 8
Join us for a discussion on how to best navigate the supply chain and still get products to market in a timely manner, amidst ever-changing barriers. Examine examples and applications of how to overcome the challenges through best practices and planning.
Click on the seminar name for cost and registration details.
**************************************
EARNINGS NEWS RELEASES
- Merck reported financial results for the third quarter of 2022. Animal health revenues were $1.37 billion, a 3% decrease compared to the prior-year quarter (+4% currency adjusted). Merck’s livestock and companion animal businesses both grew 4% for the third quarter. Year to date, Merck’s animal health business is flat compared to 2021. (Company Press Release)
- Colgate-Palmolive Company reported that it’s Hill’s Pet Nutrition business grew 7% organically in the 3rd quarter this year compared to 3Q 2021. Net sales for the quarter grew 3% when adjusted for foreign exchange. Year to date, organic revenue growth is 13%. (Company Press Release).
*********************************************
BRAKKE CONSULTING
2022 US FLEA CONTROL AND HEARTWORM MARKETS REPORT
EARLY-BIRD DISCOUNT ENDS NOV. 18
Are you on top of the trends in the largest market segment in companion animal health? Brakke Consulting will soon be publishing our 2022 report on the US Flea Control and Heartworm Markets.
The report includes valuable information on the US market for small animal parasiticides including:
– Product descriptions, prices (veterinarian cost and online pricing), and sales for the leading veterinary flea, tick and heartworm products
– an overview of the veterinary and OTC flea control markets
– discussion of new product launches
– 2022 survey of 340+ veterinarians
– 2022 survey of 500 pet owners
The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $7,495 if ordered by FRIDAY, NOVEMBER 18, and $7,995 after that date.
Please contact Dr. Lynn Fondon at 336-396-3916 or lfondon@brakkeconsulting.com to pre-order the report, or for more information visit our website.
*********************************************
COMPANY NEWS RELEASES
- Zoetis has launched Project WAG (Wellbeing and Growth), a US initiative to help veterinary professionals develop and maintain an improved standard of wellbeing in their practices. Project WAG provides all veterinary professionals, including veterinarians, veterinary technicians, and support and administrative staff, access to online resources in one place that offer tips on promoting self-care. (DVM360)
- Mars Petcare’s brand IAMS announced a partnership with Kinship’s Whistle Health, a smart pet-health monitoring brand. By leveraging Whistle Health’s smart devices, pet parents can learn more about their dog’s behaviors and select an IAMS dog food formula based specifically for their individual needs. The devices use data-driven insights based on dog behaviors. (Petfood Processing – subscription)
- Ralco announced that the Jon Knochenmus Center for Innovation is fully operational with its first research studies being conducted. The 13.6 acre site – purchased in fall 2020 – now includes a swine research barn, poultry research barn, ruminant lab, radio frequency gas production system, mycotoxin testing and particle size analysis services for Ralco customers. (company press release)
- VolitionRx announced it has signed a global supply agreement with an unnamed market leader in pet healthcare to offer the Nu.Q test for cancer indications in animal health through its reference laboratory network. Earlier this year, VolitionRx signed an exclusive deal with Heska for the global distribution of the Nu.Q Vet Cancer Screening Test at the point of care for companion animals; the deal reportedly also granted Heska non-exclusive rights to sell Nu.Q through its network of central reference laboratories. (IHS Markit Connect – subscription)
- PIC and the National Pork Board announced they are teaming up to develop a framework that will demonstrate the critical role genetics play in creating a more sustainable protein supply. (company press release)
- Bausch + Lomb Corporation announced the introduction of Project Watson health care products for dogs in the US. The new line of products is specifically formulated to help support dogs’ eyes, ears and overall wellbeing using high quality and naturally inspired ingredients. The eye wash and two supplements will be available online starting in November 2022 at Chewy, Walmart, PetSmart and Amazon; the remaining three products will be available by the end of the year. (yahoo.com)
- BrightPet Nutrition Group, a portfolio company of A&M Capital Partners (AMCP), announced it has completed the strategic acquisition of Bravo! Pet Foods, a frozen raw and freeze-dried pet diets manufacturer. Financial terms were not disclosed. (Pet Business)
- PBD Biotech announced it has secured follow-on funding of GBP 2.4 million ($2.7 million) to further develop its Actiphage diagnostic for cattle and humans. Actiphage is a rapid screening phage-based test designed to detect live mycobacteria – the pathogen that causes human tuberculosis (TB), bovine tuberculosis and Johne’s Disease. The funding is from a consortium led by fund managers Mercia and the Foresight Group, both investing from the Midlands Engine Investment Fund, alongside the University of Nottingham and private investors. (IHS Markit Connect – subscription)
- PetDx has launched its blood-based early canine cancer detection test in Asia through a company affiliated with Antech. (IHS Markit Connect– Subscription)
- UK MWI Animal Health has launched MWI Pet designed to help veterinary practices increase engagement with clients while reducing administrative burdens on staff. (businesswire)
- UK Belgian company United Petfood announced it has acquired British independent animal feed manufacturer Gold Line Feeds. Financial terms were not disclosed. (GlobalPets)
- SPAIN Cleon Capital and Columbus Venture Partners announced they have sold Algenex to Insud Pharma. Algenex is a specialist in the production of recombinant proteins for veterinary and human applications; the recombinant proteins can be used for vaccines, therapeutic molecules and diagnostic reagents. Insud Pharma is owned by Grupo Insud – an Argentine company that also has Biogénesis Bagó as one of its business units. Financial terms were not disclosed. (IHS Markit Connect – subscription)
*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER
***********************************
ANIMAL HEALTH NEWS
- US – AVIAN INFLUENZA A near-record number of US chickens and turkeys have been killed by an outbreak of avian flu this year. The outbreak has infected flocks in 42 states since February, and more than 47 million birds have died due to infections and being culled. The outbreak has led to export bans, lowered egg and turkey production, and contributed to record prices of staples ahead of the US holiday season. (com)
- US – TICKBORNE DISEASE The Kansas State Veterinary Diagnostic Laboratory, a part of the Kansas State University College of Veterinary Medicine, has developed a new unique polymerase chain reaction, or PCR, bovine test for two major blood-borne diseases in cattle: the endemic disease anaplasmosis and the emerging disease Theileriosis. These insect vector-transmitted diseases are caused primarily in the U.S. by the American dog tick for anaplasmosis, and the Asian longhorned tick for Theileria. (Feedstuffs – subscription)
- US – CANINE IMMUNOTHERAPY The University of Pennsylvania announced it has received a $500,000+ grant from the National Institutes of Health (NIH) to advance the work of the Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) to support clinical trials of immunotherapies in dogs for another five years. (IHS Markit Connect – subscription)
- EUROPE European partners are set to work together on sustainable breeding programs for endangered breeds of food-producing animals. Wageningen University & Research (WUR), L’institut de l’Elevage (IDELE) and Bundesanstalt für Landwirtschaft und Ernährung (BLE) are advising the European Commission, national governments and breed organizations on sustainable breeding programs for endangered food animal breeds, as well as the implementation of EU breeding regulations. This project will commence on January 1, 2023. (IHS Markit Connect – subscription)
- THAILAND – AQUACULTURE Researchers at Chulalongkorn University, in partnership with the Center of Excellence in Fish Infectious Diseases (CE FID) and Aqua Innovac Co. Ltd., have developed Flavo Innovac, an inactivated Flavobacterium nanovaccine for the prevention of bacterial gills diseases in freshwater fish species such as Tilapia and freshwater Asian sea bass. Using the needle–free Aqua Innovac, fish are vaccinated by immersing them in water mixed with the vaccine for approximately 20-30 min. (Newswise)
************************************
BRAKKE CONSULTING VIEWPOINT
AVMA held its 10th annual Veterinary Business and Economic Forum earlier this week. If you like data, you’d love this conference. It’s a chock full of results from the latest AVMA studies, as well presentations on other research and economic data. Attendance has grown steadily from a few dozen people in 2013 to several hundred today, aided in recent years by its online format.
Dana Peterson, chief economist of the Conference Board was the keynote speaker and gave an excellent overview of the state of the US economy. The Conference Board is predicting a US recession in late 2022 or 2023, but does not expect it to be a deep recession. Even if there is a recession, veterinarians are likely to fair well, however. There was ample evidence presented at the Forum that demand for veterinary services is strong and will likely continue that way.
Kudos to AVMA for hosting a very worthwhile event.
Speaking of data, the Brakke US Flea Control and Heartworm Market Report will be available soon. Flea control is the biggest single product category in animal health and this study provides a great overview of the products and market trends. Take advantage of the early order period! It’s one of our most popular studies.
John Volk
***********************************
YOUR VIEW
Last week we asked, “How concerned are you with the privacy of data collected on pet and farm animals and their owners?” 24% of you said “very concerned,” 37% said somewhat concerned, and 39% were not very or at all concerned. I’m curious how responses might have changed if we had said “pet and livestock” and not “owners.”
Given the Conference Board’s forecast of a recession in late 2022 or 2023, let’s see if you agree.
This Week
English (United States) 
Portuguese